SLB N.V. vs Regeneron Pharmaceuticals, Inc.
時価総額の推移比較
SLB N.V.
$67.5B
順位 #238
Regeneron Pharmaceuticals, Inc.
$68.6B
順位 #236
時価総額の推移
主な転換点
- Regeneron Pharmaceuticals, Inc.が2020年までにSLB N.V.を上回った
年次比較
| 年 | SLB N.V. | Regeneron Pharmaceuticals, Inc. | 首位 |
|---|---|---|---|
| 2026 | $67.5B | $68.6B | Regeneron Pharmaceuticals, Inc. |
| 2025 | $56.3B | $79.3B | Regeneron Pharmaceuticals, Inc. |
| 2024 | $54.6B | $72.8B | Regeneron Pharmaceuticals, Inc. |
| 2023 | $72.4B | $89.7B | Regeneron Pharmaceuticals, Inc. |
| 2022 | $73.1B | $73.7B | Regeneron Pharmaceuticals, Inc. |
| 2021 | $40.5B | $64.5B | Regeneron Pharmaceuticals, Inc. |
| 2020 | $28.8B | $49.4B | Regeneron Pharmaceuticals, Inc. |
| 2019 | $50.9B | $38.4B | SLB N.V. |
| 2018 | $43.4B | $38.2B | SLB N.V. |
| 2017 | $78.6B | $38.4B | SLB N.V. |
| 2016 | $95.3B | $37.5B | SLB N.V. |
| 2015 | $77.6B | $55.5B | SLB N.V. |
| 2014 | $92.3B | $41.9B | SLB N.V. |
| 2013 | $95.9B | $28.1B | SLB N.V. |
| 2012 | $72.9B | $17.5B | SLB N.V. |
| 2011 | $70.7B | $5.7B | SLB N.V. |
| 2010 | $85.4B | $3.4B | SLB N.V. |
| 2009 | $65.7B | $2.5B | SLB N.V. |
| 2008 | $41.9B | $1.9B | SLB N.V. |
| 2007 | $96.5B | $2.5B | SLB N.V. |
| 2006 | $61.4B | $2.1B | SLB N.V. |
| 2005 | $46.8B | $1.6B | SLB N.V. |
| 2004 | $31.9B | $941.1M | SLB N.V. |
| 2003 | $25.8B | $1.5B | SLB N.V. |
| 2002 | $19.5B | $1.9B | SLB N.V. |
| 2001 | $25.1B | $2.9B | SLB N.V. |
| 2000 | $36.0B | $3.6B | SLB N.V. |
| 1999 | $22.2B | $1.3B | SLB N.V. |
| 1998 | $18.1B | $753.6M | SLB N.V. |
| 1997 | $31.0B | $874.9M | SLB N.V. |
| 1996 | $19.0B | $1.6B | SLB N.V. |
| 1995 | $12.9B | $1.3B | SLB N.V. |
| 1994 | $9.2B | $306.5M | SLB N.V. |